Who are Syncardia's investors?

Syncardia's investors include Hunniwell Lake Ventures LLC.

How much funding has Syncardia raised?

Syncardia has disclosed $6.4M raised across 1 round.

Where is Syncardia headquartered?

Syncardia is headquartered in Tucson, US.

Syncardia

Tucson, US · 1 known investors

SynCardia develops the SynCardia Total Artificial Heart (STAH), an FDA-approved device that replaces both failing ventricles to restore blood flow as a bridge to heart transplant. It serves transplant-eligible patients with end-stage biventricular heart failure and the physicians and hospitals treating them.

Hardware Healthtech Medical Devices

Founders & leadership

Michael GarippaNamed on SEC filing

Doug David FahouryNamed on SEC filing

Mark C. Goldberg, M.D.Named on SEC filing

Jack G. Copeland, M.D.Named on SEC filing

Luis BurgosNamed on SEC filing

Douglas A. NutterNamed on SEC filing

Thomas K. CoxNamed on SEC filing

Harry GeorgeNamed on SEC filing

Kirk CollamerNamed on SEC filing

Eric SalzmanNamed on SEC filing

Investors · 1

Hunniwell Lake Ventures LLCPalo Alto

Reported raises · per SEC filings

Form D private placements

$6.4M disclosed across 1 round · 2014

▶$6.4MraisedOct 2014 · 83 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael GarippaExecutive Officer, Director
Doug David FahouryDirector
Mark C. Goldberg, M.D.Director
Jack G. Copeland, M.D.Director
Luis BurgosExecutive Officer
Douglas A. NutterExecutive Officer
Thomas K. CoxDirector
Harry GeorgeDirector
Kirk CollamerExecutive Officer
Eric SalzmanDirector

Offering amount: $15M
Amount sold: $6.4M
First sale: Sep 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Syncardia do?: SynCardia develops the SynCardia Total Artificial Heart (STAH), an FDA-approved device that replaces both failing ventricles to restore blood flow as a bridge to heart transplant. It serves transplant-eligible patients with end-stage biventricular heart failure and the physicians and hospitals treating them.
Who are Syncardia's investors?: Syncardia's investors include Hunniwell Lake Ventures LLC.
How much funding has Syncardia raised?: Syncardia has disclosed $6.4M raised across 1 round.
Where is Syncardia headquartered?: Syncardia is headquartered in Tucson, US.